Press release
Asia Pacific Biobanking Market Size, Share, Report and Forecast 2024-2032
The global biobanking market size was valued at USD 72.1 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by the increased investments from both government and private sectors in biobanking. It is expected to grow at a CAGR of 6.89% during the forecast period of 2024-2032, with the values likely to attain USD 131.1 billion by 2032.
Biobanking: Introduction
Biobanking is a critical component of modern biomedical research, serving as a repository for biological samples such as blood, tissue, and DNA. These banks provide a valuable resource for scientific studies, enabling advancements in personalized medicine, disease prevention, and therapeutic development. By preserving high-quality specimens, biobanks support large-scale studies on genetic and environmental factors affecting health. Additionally, they facilitate collaborative research efforts, offering a centralized source of data for scientists worldwide. The growth of biobanking is driven by technological advancements and increasing recognition of its role in enhancing healthcare outcomes, making it an indispensable tool in the quest for medical innovation and public health improvement.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/asia-pacific-biobanking-market/requestsample
Key Trends in the Asia Pacific Biobanking Market
The Asia Pacific biobanking market is experiencing significant growth, driven by advancements in medical research and the increasing need for high-quality biological samples. Key trends shaping this market are technological innovations, growing government support, and the rising prevalence of chronic diseases.
Key trends in the Asia Pacific biobanking market are as follows:
Technological Advancements: The integration of advanced technologies such as automation, artificial intelligence (AI), and blockchain in biobanking processes is enhancing the efficiency and accuracy of sample storage, retrieval, and data management. These technologies improve the traceability and integrity of samples, facilitating more reliable research outcomes.
Government and Institutional Support: Governments and health institutions across the Asia Pacific region are increasingly recognizing the importance of biobanks in advancing medical research and public health. Investments and funding initiatives are being directed towards the establishment and expansion of biobanking infrastructure, fostering growth in this sector.
Rising Prevalence of Chronic Diseases: The growing incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is driving the demand for biobanking services. Biobanks play a crucial role in collecting and storing samples necessary for understanding these diseases and developing targeted therapies, contributing to better patient outcomes.
Expansion of Personalized Medicine: Personalized medicine, which tailors treatment based on individual genetic profiles, is gaining traction in the Asia Pacific region. Biobanks provide essential genetic material and data that enable researchers to identify biomarkers and develop personalized treatment plans, accelerating the adoption of precision medicine.
Collaborative Research Initiatives: There is a growing trend towards collaborative research, with biobanks serving as central repositories for multi-institutional studies. This collaboration enhances the scope and scale of research, leading to more comprehensive findings and advancements in medical science.
Ethical and Regulatory Developments: The Asia Pacific region is seeing the implementation of stringent ethical guidelines and regulatory frameworks to ensure the responsible use of biobanked samples. These measures aim to protect donor privacy and maintain high ethical standards, thereby increasing public trust and participation in biobanking initiatives.
Asia Pacific Biobanking Market Segmentation
Market Breakup by Product and Service
Equipment
Consumables
Service
Software
Market Breakup by Application
Regenerative Medicine
Life Science Research
Clinical Research
Market Breakup by Sample Type
Blood Tissue
Nucleic Acids
Cell Lines
Market Breakup by End User
Academic Institutions
Pharma and Biotech Companies
Market Breakup by Country
China
Japan
India
ASEAN
Australia
Others
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/asia-pacific-biobanking-market
Asia Pacific Biobanking Market Overview
The Asia Pacific biobanking market is experiencing robust growth, driven by advancements in biomedical research and the increasing importance of personalized medicine.
In China, the market benefits from significant government investment in healthcare infrastructure and research, with numerous large-scale biobanking initiatives supporting genetic and clinical research. China's focus on precision medicine is a major growth driver.
Japan, known for its advanced technological capabilities, has a well-established biobanking market. The country's aging population and high prevalence of chronic diseases are key factors driving the demand for biobanked samples to support medical research and drug development.
India's biobanking market is rapidly expanding, supported by a large and genetically diverse population, increasing healthcare expenditure, and growing research activities. Government initiatives and collaborations between academic institutions and pharmaceutical companies are further propelling market growth.
In the ASEAN region, countries such as Singapore, Malaysia, and Thailand are making significant strides in biobanking. These nations are investing in healthcare infrastructure and research facilities, aiming to become regional hubs for biomedical research and biobanking.
Australia's biobanking market is well-developed, with strong government support and advanced research institutions. The country's focus on translational research and personalized medicine is driving demand for high-quality biobanked samples.
Other countries in the Asia Pacific region are also contributing to the market's growth, leveraging regional collaborations and increasing investments in healthcare and research.
Asia Pacific Biobanking Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
PHC Holdings Corporation
PHC Holdings Corporation, headquartered in Tokyo, Japan, is a global healthcare company specializing in medical devices, healthcare IT, and life sciences. Established in 1969, PHC Holdings offers a wide range of products and services, including diabetes management solutions, diagnostics, and biomedical laboratory equipment. The company is committed to improving healthcare outcomes through innovation and advanced technology. With a strong presence in over 125 countries, PHC Holdings collaborates with healthcare providers to deliver high-quality solutions that enhance patient care and operational efficiency. The company's dedication to research and development drives its continuous growth and contribution to global healthcare advancements.
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. is a global leader in serving science, headquartered in Waltham, Massachusetts. The company provides a comprehensive range of products and services, including analytical instruments, laboratory equipment, software, consumables, and reagents, catering to healthcare, life sciences, and industrial applications. Thermo Fisher is renowned for its innovation and commitment to advancing scientific research and healthcare. Through its diverse portfolio and strategic acquisitions, the company supports its customers in accelerating research, improving diagnostics, and enhancing laboratory productivity. With a global presence and a focus on customer-centric solutions, Thermo Fisher drives scientific discovery and innovation worldwide.
Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a leading global medical technology company headquartered in Franklin Lakes, New Jersey. Founded in 1897, BD specializes in developing, manufacturing, and selling medical devices, instrument systems, and reagents. The company's product portfolio spans various healthcare sectors, including diagnostics, biosciences, and medical devices, with a strong focus on improving medication management and infection prevention. BD is renowned for its innovations in drug delivery systems, diagnostic solutions, and laboratory automation. Committed to advancing the world of health, BD collaborates with healthcare institutions worldwide to enhance patient care and improve healthcare outcomes.
QIAGEN N.V.
QIAGEN N.V. is a leading global provider of Sample to Insight solutions that enable customers to gain valuable insights from molecular samples. Headquartered in Venlo, Netherlands, QIAGEN offers a comprehensive portfolio of products and services for sample preparation, molecular diagnostics, and bioinformatics. The company's innovative technologies are widely used in clinical diagnostics, pharmaceutical research, and academic research to detect and analyze genetic information. QIAGEN's solutions empower scientists and healthcare professionals to make breakthroughs in areas such as disease detection, drug development, and personalized medicine. With a global presence, QIAGEN is committed to advancing molecular science and improving human health.
Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a leading global science and technology company specializing in healthcare, life science, and performance materials. Founded in 1668, it operates in over 70 countries, focusing on innovative solutions to improve quality of life. In healthcare, Merck KGaA develops prescription medicines, biopharmaceutical therapies, and fertility treatments. Its life science division offers tools and services for research and biotech production, while the performance materials division provides products for electronics, cosmetics, and coatings. Committed to sustainability and scientific excellence, Merck KGaA continuously invests in research and development to drive innovation across its diverse portfolio.
Other key players in the market include Avantor, Inc., Cryoport, Inc., Tecan Trading AG, Lifecode Technologies Pte Ltd, and China Cord Blood Corporation.
Related Report
DNA Sequencing Products Market
https://www.expertmarketresearch.com/reports/dna-sequencing-products-market
Autologous Cell Therapy Market
https://www.expertmarketresearch.com/reports/autologous-cell-therapy-market
Smart Implantable Pumps Market
https://www.expertmarketresearch.com/reports/smart-implantable-pumps-market
Healthcare Gamification Market
https://www.expertmarketresearch.com/reports/healthcare-gamification-market
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia Pacific Biobanking Market Size, Share, Report and Forecast 2024-2032 here
News-ID: 3552484 • Views: …
More Releases from Expert Market Research
Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
The global bed and bath linen market is witnessing strong growth due to increasing consumer focus on home décor, comfort, and luxury. Rising disposable incomes, urbanization, and the booming hospitality sector are further boosting demand for premium-quality bed sheets, pillowcases, towels, and bathrobes. Technological innovations in fabrics, such as antimicrobial, wrinkle-resistant, and sustainable textiles, are shaping consumer preferences. In addition, the expansion of online distribution channels has made luxury and…
Global Fruit Juice Market Size, Report and Forecast 2025-2034
The latest report from Expert Market Research titled, "Global Fruit Juice Market Size, Report and Forecast 2025-2034," offers a comprehensive analysis of the global fruit juice market, examining it across various segments such as types, flavours, distribution channels, and key regions.
The report identifies and tracks the latest trends shaping the industry and evaluates their impact on the overall market dynamics. It also provides a thorough assessment of the market, covering…
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
According to the latest report by Expert Market Research (EMR), the global Fluorspar Market Size is projected to grow at a CAGR of 5.60% between 2025 and 2034. The market is expected to experience significant growth by 2034, driven by the increasing demand for fluorspar across industries such as manufacturing, chemicals, and metallurgy.
Fluorspar, also known as fluorite, is a key industrial mineral composed of calcium fluoride (CaF2). It is crucial…
Why will smart pulse oximeters market hit $3.50Bn by 2034?
smart pulse oximeters market Overview
The smart pulse oximeters market has become a pivotal part of modern healthcare infrastructure, especially in the wake of increasing cardiovascular and respiratory ailments. These technologically enhanced devices measure blood oxygen saturation and pulse rate, often offering wireless connectivity to mobile apps for better health tracking. Their growing application in hospitals, ambulatory settings, and home healthcare environments reflects the market's evolving dynamics. Key drivers include the…
More Releases for Asia
Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value.
https://boomingfaucet.com/
Asia Private Equity Consulting
E-mail:nolan@pandacuads.com
In China,…
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,…
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022.
23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property…
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019".
The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn…
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia
Equipping Asia’s navies with the latest diving technology for asymmetric warfare and
operations
SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is
seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting…
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients.
Asked to comment on the move, Luke Palmer, the…
